269 related articles for article (PubMed ID: 22877866)
1. Long-term clinical outcome after intramuscular transplantation of granulocyte colony stimulating factor-mobilized CD34 positive cells in patients with critical limb ischemia.
Kinoshita M; Fujita Y; Katayama M; Baba R; Shibakawa M; Yoshikawa K; Katakami N; Furukawa Y; Tsukie T; Nagano T; Kurimoto Y; Yamasaki K; Handa N; Okada Y; Kuronaka K; Nagata Y; Matsubara Y; Fukushima M; Asahara T; Kawamoto A
Atherosclerosis; 2012 Oct; 224(2):440-5. PubMed ID: 22877866
[TBL] [Abstract][Full Text] [Related]
2. Intramuscular transplantation of G-CSF-mobilized CD34(+) cells in patients with critical limb ischemia: a phase I/IIa, multicenter, single-blinded, dose-escalation clinical trial.
Kawamoto A; Katayama M; Handa N; Kinoshita M; Takano H; Horii M; Sadamoto K; Yokoyama A; Yamanaka T; Onodera R; Kuroda A; Baba R; Kaneko Y; Tsukie T; Kurimoto Y; Okada Y; Kihara Y; Morioka S; Fukushima M; Asahara T
Stem Cells; 2009 Nov; 27(11):2857-64. PubMed ID: 19711453
[TBL] [Abstract][Full Text] [Related]
3. Transplantation of purified CD34+ cells in the treatment of critical limb ischemia.
Dong Z; Chen B; Fu W; Wang Y; Guo D; Wei Z; Xu X; Mendelsohn FO
J Vasc Surg; 2013 Aug; 58(2):404-411.e3. PubMed ID: 23611711
[TBL] [Abstract][Full Text] [Related]
4. A randomized, controlled pilot study of autologous CD34+ cell therapy for critical limb ischemia.
Losordo DW; Kibbe MR; Mendelsohn F; Marston W; Driver VR; Sharafuddin M; Teodorescu V; Wiechmann BN; Thompson C; Kraiss L; Carman T; Dohad S; Huang P; Junge CE; Story K; Weistroffer T; Thorne TM; Millay M; Runyon JP; Schainfeld R;
Circ Cardiovasc Interv; 2012 Dec; 5(6):821-30. PubMed ID: 23192920
[TBL] [Abstract][Full Text] [Related]
5. Autologous Granulocyte Colony-Stimulating Factor-Mobilized Peripheral Blood CD34 Positive Cell Transplantation for Hemodialysis Patients with Critical Limb Ischemia: A Prospective Phase II Clinical Trial.
Ohtake T; Mochida Y; Ishioka K; Oka M; Maesato K; Moriya H; Hidaka S; Higashide S; Ioji T; Fujita Y; Kawamoto A; Fukushima M; Kobayashi S
Stem Cells Transl Med; 2018 Nov; 7(11):774-782. PubMed ID: 30059194
[TBL] [Abstract][Full Text] [Related]
6. Rationale and design of the MarrowStim PAD Kit for the Treatment of Critical Limb Ischemia in Subjects with Severe Peripheral Arterial Disease (MOBILE) trial investigating autologous bone marrow cell therapy for critical limb ischemia.
Wang SK; Green LA; Motaganahalli RL; Wilson MG; Fajardo A; Murphy MP
J Vasc Surg; 2017 Jun; 65(6):1850-1857.e2. PubMed ID: 28390770
[TBL] [Abstract][Full Text] [Related]
7. Autologous Cell Therapy for Peripheral Arterial Disease: Systematic Review and Meta-Analysis of Randomized, Nonrandomized, and Noncontrolled Studies.
Rigato M; Monami M; Fadini GP
Circ Res; 2017 Apr; 120(8):1326-1340. PubMed ID: 28096194
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of therapeutic angiogenesis as a novel treatment in patients with critical limb ischemia.
Lara-Hernandez R; Lozano-Vilardell P; Blanes P; Torreguitart-Mirada N; Galmés A; Besalduch J
Ann Vasc Surg; 2010 Feb; 24(2):287-94. PubMed ID: 20142004
[TBL] [Abstract][Full Text] [Related]
9. Lumbar sympathectomy versus prostanoids for critical limb ischaemia due to non-reconstructable peripheral arterial disease.
Sen I; Agarwal S; Tharyan P; Forster R
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD009366. PubMed ID: 29658630
[TBL] [Abstract][Full Text] [Related]
10. The Efficacy of Percutaneous Transluminal Angioplasty on the Limb Salvage and Recovery of Symptoms in Patients With Buerger's Disease With Critical Limb Ischemia.
Rodoplu O; Yildiz CE; Oztas DM; Conkbayir C; Unal O; Ulukan MO; Meric M; Ugurlucan M; Kirbas A
J Invasive Cardiol; 2020 Jun; 32(6):E158-E167. PubMed ID: 32479418
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic angiogenesis in Buerger's disease (thromboangiitis obliterans) patients with critical limb ischemia by autologous transplantation of bone marrow mononuclear cells.
Motukuru V; Suresh KR; Vivekanand V; Raj S; Girija KR
J Vasc Surg; 2008 Dec; 48(6 Suppl):53S-60S; discussion 60S. PubMed ID: 19084740
[TBL] [Abstract][Full Text] [Related]
12. Autologous bone-marrow mononuclear cell implantation reduces long-term major amputation risk in patients with critical limb ischemia: a comparison of atherosclerotic peripheral arterial disease and Buerger disease.
Idei N; Soga J; Hata T; Fujii Y; Fujimura N; Mikami S; Maruhashi T; Nishioka K; Hidaka T; Kihara Y; Chowdhury M; Noma K; Taguchi A; Chayama K; Sueda T; Higashi Y
Circ Cardiovasc Interv; 2011 Feb; 4(1):15-25. PubMed ID: 21205941
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of sustained release of basic fibroblast growth factor using gelatin hydrogel in patients with critical limb ischemia.
Kumagai M; Marui A; Tabata Y; Takeda T; Yamamoto M; Yonezawa A; Tanaka S; Yanagi S; Ito-Ihara T; Ikeda T; Murayama T; Teramukai S; Katsura T; Matsubara K; Kawakami K; Yokode M; Shimizu A; Sakata R
Heart Vessels; 2016 May; 31(5):713-21. PubMed ID: 25861983
[TBL] [Abstract][Full Text] [Related]
14. Long-term clinical outcomes for patients with lower limb ischemia implanted with G-CSF-mobilized autologous peripheral blood mononuclear cells.
Horie T; Onodera R; Akamastu M; Ichikawa Y; Hoshino J; Kaneko E; Iwashita C; Ishida A; Tsukamoto T; Teramukai S; Fukushima M; Kawamura A;
Atherosclerosis; 2010 Feb; 208(2):461-6. PubMed ID: 19720375
[TBL] [Abstract][Full Text] [Related]
15. Adverse events during treatment of critical limb ischemia with autologous peripheral blood mononuclear cell implant.
Jonsson TB; Larzon T; Arfvidsson B; Tidefelt U; Axelsson CG; Jurstrand M; Norgren L
Int Angiol; 2012 Feb; 31(1):77-84. PubMed ID: 22330628
[TBL] [Abstract][Full Text] [Related]
16. Transfection of human HGF plasmid DNA improves limb salvage in Buerger's disease patients with critical limb ischemia.
Shigematsu H; Yasuda K; Sasajima T; Takano T; Miyata T; Ohta T; Tanemoto K; Obitsu Y; Iwai T; Ozaki S; Ogihara T; Morishita R;
Int Angiol; 2011 Apr; 30(2):140-9. PubMed ID: 21427651
[TBL] [Abstract][Full Text] [Related]
17. Interim analysis results from the RESTORE-CLI, a randomized, double-blind multicenter phase II trial comparing expanded autologous bone marrow-derived tissue repair cells and placebo in patients with critical limb ischemia.
Powell RJ; Comerota AJ; Berceli SA; Guzman R; Henry TD; Tzeng E; Velazquez O; Marston WA; Bartel RL; Longcore A; Stern T; Watling S
J Vasc Surg; 2011 Oct; 54(4):1032-41. PubMed ID: 21684715
[TBL] [Abstract][Full Text] [Related]
18. Phase II clinical trial of CD34+ cell therapy to explore endpoint selection and timing in patients with critical limb ischemia.
Fujita Y; Kinoshita M; Furukawa Y; Nagano T; Hashimoto H; Hirami Y; Kurimoto Y; Arakawa K; Yamazaki K; Okada Y; Katakami N; Uno E; Matsubara Y; Fukushima M; Nada A; Losordo DW; Asahara T; Okita Y; Kawamoto A
Circ J; 2014; 78(2):490-501. PubMed ID: 24257136
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Long-term Outcomes of Heparin Bonded Polytetrafluoroethylene and Autologous Vein Below Knee Femoropopliteal Bypasses in Patients with Critical Limb Ischaemia.
Uhl C; Grosch C; Hock C; Töpel I; Steinbauer M
Eur J Vasc Endovasc Surg; 2017 Aug; 54(2):203-211. PubMed ID: 28587797
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of Transpedal Retrograde Approach in Endovascular Treatment of Patients With Buerger's Disease.
Tatli E; Buturak A; Vatan MB; Kurt Ömürlü I; Erkin A
J Invasive Cardiol; 2023 Feb; 36(2):E84-E91. PubMed ID: 36562796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
